These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28238947)

  • 121. A Combined Bayesian and Similarity-Based Approach for Predicting
    Stepanov D; Buchmann D; Schultze N; Wolber G; Schaufler K; Guenther S; Belik V
    J Nat Prod; 2022 Oct; 85(10):2255-2265. PubMed ID: 36107719
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of
    Ilic M; Holy M; Jaentsch K; Liechti ME; Lubec G; Baumann MH; Sitte HH; Luethi D
    Front Pharmacol; 2020; 11():673. PubMed ID: 32508638
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Efficient and cost-effective experimental determination of kinetic constants and data: the success of a Bayesian systematic approach to drug transport, receptor binding, continuous culture and cell transport kinetics.
    Murphy EF; Gilmour SG; Crabbe MJ
    FEBS Lett; 2004 Jan; 556(1-3):193-8. PubMed ID: 14706849
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Making the Most of Nothing: One-Class Classification for Single-Molecule Transport Studies.
    Bro-Jørgensen W; Hamill JM; Mezei G; Lawson B; Rashid U; Halbritter A; Kamenetska M; Kaliginedi V; Solomon GC
    ACS Nanosci Au; 2024 Aug; 4(4):250-262. PubMed ID: 39184833
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations.
    Riede J; Poller B; Huwyler J; Camenisch G
    Drug Metab Dispos; 2017 May; 45(5):523-531. PubMed ID: 28254950
    [TBL] [Abstract][Full Text] [Related]  

  • 126. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
    Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
    Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions.
    Shitara Y; Sugiyama Y
    Pharmacol Ther; 2017 Sep; 177():67-80. PubMed ID: 28249706
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration.
    Miura T; Tachikawa M; Ohtsuka H; Fukase K; Nakayama S; Sakata N; Motoi F; Naitoh T; Katayose Y; Uchida Y; Ohtsuki S; Terasaki T; Unno M
    J Pharm Sci; 2017 Sep; 106(9):2499-2508. PubMed ID: 28249806
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2).
    Pedersen JM; Khan EK; Bergström CAS; Palm J; Hoogstraate J; Artursson P
    Eur J Pharm Sci; 2017 May; 103():70-76. PubMed ID: 28263911
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Novel Method to Predict In Vivo Liver-to-Plasma K
    Riccardi K; Lin J; Li Z; Niosi M; Ryu S; Hua W; Atkinson K; Kosa RE; Litchfield J; Di L
    Drug Metab Dispos; 2017 May; 45(5):576-580. PubMed ID: 28258068
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay.
    Gilibili RR; Chatterjee S; Bagul P; Mosure KW; Murali BV; Mariappan TT; Mandlekar S; Lai Y
    Drug Metab Dispos; 2017 Jun; 45(6):604-611. PubMed ID: 28325716
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites.
    Li R; Bi YA; Vildhede A; Scialis RJ; Mathialagan S; Yang X; Marroquin LD; Lin J; Varma MVS
    Drug Metab Dispos; 2017 Jul; 45(7):737-747. PubMed ID: 28438781
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Progress in the Molecular Characterization of Hepatobiliary Transporters.
    Keppler D
    Dig Dis; 2017; 35(3):197-202. PubMed ID: 28249282
    [TBL] [Abstract][Full Text] [Related]  

  • 135. In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions.
    Zhang Q; Zhang Y; Boer J; Shi JG; Hu P; Diamond S; Yeleswaram S
    Drug Metab Dispos; 2017 Jun; 45(6):612-623. PubMed ID: 28283500
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    De Lombaerde S; Neyt S; Kersemans K; Verhoeven J; Devisscher L; Van Vlierberghe H; Vanhove C; De Vos F
    PLoS One; 2017; 12(3):e0173529. PubMed ID: 28273180
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Targeted pharmacotherapies for defective ABC transporters.
    Vauthier V; Housset C; Falguières T
    Biochem Pharmacol; 2017 Jul; 136():1-11. PubMed ID: 28245962
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way.
    Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA
    Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2.
    Sjöstedt N; van den Heuvel JJMW; Koenderink JB; Kidron H
    Pharm Res; 2017 Aug; 34(8):1626-1636. PubMed ID: 28281205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.